Alexander Nowak
Stock Analyst at Craig-Hallum
(4.39)
# 375
Out of 4,641 analysts
45
Total ratings
54.55%
Success rate
20.35%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BVS Bioventus | Maintains: Buy | $12 → $17 | $12.97 | +31.07% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $39.65 | +43.76% | 6 | Sep 5, 2024 | |
| CVRX CVRx, Inc. | Maintains: Buy | $23 → $15 | $10.15 | +47.78% | 3 | Jul 11, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $16.35 | +65.14% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $23.14 | -35.18% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $4.30 | +86.05% | 4 | Apr 24, 2024 | |
| NTRA Natera | Assumes: Buy | $117 | $119.95 | -2.46% | 3 | Apr 8, 2024 | |
| AXDX Accelerate Diagnostics | Maintains: Hold | $2 → $1 | $1.86 | -46.24% | 3 | Apr 1, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $6.13 | +193.64% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $33.54 | +49.08% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $0.95 | +740.95% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $70.58 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.92 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $1.95 | +464.10% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $69.95 | +57.26% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.36 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $2.63 | +11,306.84% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $6.76 | +314.20% | 1 | Aug 31, 2020 |
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $12.97
Upside: +31.07%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $39.65
Upside: +43.76%
CVRx, Inc.
Jul 11, 2024
Maintains: Buy
Price Target: $23 → $15
Current: $10.15
Upside: +47.78%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $16.35
Upside: +65.14%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $23.14
Upside: -35.18%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $4.30
Upside: +86.05%
Natera
Apr 8, 2024
Assumes: Buy
Price Target: $117
Current: $119.95
Upside: -2.46%
Accelerate Diagnostics
Apr 1, 2024
Maintains: Hold
Price Target: $2 → $1
Current: $1.86
Upside: -46.24%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $6.13
Upside: +193.64%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $33.54
Upside: +49.08%
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $0.95
Upside: +740.95%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $70.58
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.92
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $1.95
Upside: +464.10%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $69.95
Upside: +57.26%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.36
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $2.63
Upside: +11,306.84%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $6.76
Upside: +314.20%